Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Addition of 5-Azacitidine to Standard Induction Therapy Is Feasible In Older Patients with Acute Myeloid Leukemia: The AML-AZA Trial of the SAL Study Group

Utz O Krug, MD, Anja Koschmieder, Joachim Gerss, PhD, Hubert Serve, MD, Björn Steffen, MD, Gesine Bug, MD, Markus Schaich, MD, Christian Brandts, MD, Christoph Röllig, MD, Gerhard Ehninger, MD, Ulrich Duehrsen, MD, Richard Noppeney, MD, Wolfgang E. Berdel, MD, Steffen Koschmieder, MD, Carsten Müller-Tidow, MD

Blood (2010) 116 (21): 2180.

https://doi.org/10.1182/blood.V116.21.2180.2180

Published: 2010

Journal Articles

Kinase Activity of RTKs Is Dispensable for Factor Independent Growth and Transformation of a Myeloid Cell Line 32D in the Presence of Cbl Mutants.

Bülent Sargin on behalf of the Study Alliance Leukemias (SAL), Srinivasa Rao Bandi, Marion Rensinghoff, Rebekka Grundler, Lara Tickenbrock, Justus Duyster, Wolfgang E Berdel, Christian Brandts, MD, Hubert Serve, Carsten Müller-Tidow

Blood (2009) 114 (22): 3970.

https://doi.org/10.1182/blood.V114.22.3970.3970

Published: 2009

Journal Articles

Myeloproliferative Disease or Myeloid Leukemia Caused by Cbl Mutants in a Mouse Transplantation Model.

Bülent Sargin on behalf of the Study Alliance Leukemias (SAL), Srinivasa Rao Bandi, Marion Rensinghoff, Rebekka Grundler, Lara Tickenbrock, Gabriele Köhler, Justus Duyster, Wolfgang E Berdel, Hubert Serve, Christian Brandts, MD, Carsten Müller-Tidow

Blood (2009) 114 (22): 3973.

https://doi.org/10.1182/blood.V114.22.3973.3973

Published: 2009

Journal Articles

Activation of AKT1 in Hematopoietic Stem Cells Causes a Myeloproliferative Disease in a Tet-Inducible Mouse Model.

Christian Brandts, MD, Miriam Rode, PhD, Beate Lindtner, MA, Gabriele Koehler, MD, Steffen Koschmieder, MD, Carsten Mueller-Tidow, Wolfgang E. Berdel, Hubert Serve

Blood (2008) 112 (11): 1356.

https://doi.org/10.1182/blood.V112.11.1356.1356

Published: 2008

Journal Articles

Frequent CBL Mutations Associated with 11q Acquired Uniparental Disomy in Myeloproliferative Neoplasms

Francis Grand, PhD, Claire Hidalgo-Curtis, BSc, Thomas Ernst, MD, Katerina Zoi, PhD, Christine Zoi, MD, Carolann McGuire, PhD, Sebastian Kreil, MD, Georgia Metzgeroth, MD, David Oscier, MD, Andrew Hall, PhD, Christian Brandts, MD, Hubert Serve, Andreas Reiter, MD, Andrew Chase, PhD, Nicholas C.P. Cross, PhD

Blood (2008) 112 (11): 174.

https://doi.org/10.1182/blood.V112.11.174.174

Published: 2008

NARROW

Addition of 5-Azacitidine to Standard Induction Therapy Is Feasible In Older Patients with Acute Myeloid Leukemia: The AML-AZA Trial of the SAL Study Group

Kinase Activity of RTKs Is Dispensable for Factor Independent Growth and Transformation of a Myeloid Cell Line 32D in the Presence of Cbl Mutants.

Myeloproliferative Disease or Myeloid Leukemia Caused by Cbl Mutants in a Mouse Transplantation Model.

Activation of AKT1 in Hematopoietic Stem Cells Causes a Myeloproliferative Disease in a Tet-Inducible Mouse Model.

Frequent CBL Mutations Associated with 11q Acquired Uniparental Disomy in Myeloproliferative Neoplasms

Email alerts

ASH Publications

American Society of Hematology

Addition of 5-Azacitidine to Standard Induction Therapy Is Feasible In Older Patients with Acute Myeloid Leukemia: The AML-AZA Trial of the SAL Study Group

Kinase Activity of RTKs Is Dispensable for Factor Independent Growth and Transformation of a Myeloid Cell Line 32D in the Presence of Cbl Mutants.

Myeloproliferative Disease or Myeloid Leukemia Caused by Cbl Mutants in a Mouse Transplantation Model.

Activation of AKT1 in Hematopoietic Stem Cells Causes a Myeloproliferative Disease in a Tet-Inducible Mouse Model.

Frequent CBL Mutations Associated with 11q Acquired Uniparental Disomy in Myeloproliferative Neoplasms

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only